Omgeo, Enfusion Partner on Listed Derivatives

Ted Leveroni, Omgeo

The post-trade solutions provider will connect its Central Trade Manager for domestic and cross-border exchange-traded derivatives (ETDs) with Enfusion's Integráta buy-side portfolio management solution.

The solution, targeted at hedge funds and other alternative managers, will enable firms to centrally match, allocate, and confirm contracts-for-difference, equities, and fixed income transactions. The new offering will also standardize post-trade workflow for ETD trades, and reduce operational risk by supporting both execution and clearing messages at once.

“As hedge funds continue to boost their trading strategies with listed derivatives, they need to ensure their middle- and back-office processes keep pace with their front-office activities. The new joint offering highlights Omgeo’s aim to facilitate efficiency across the evolving global markets, increasing automation and lowering risk for buy- and sell-side firms alike," Ted Leveroni, executive director of derivative strategy at Omgeo, says.

  • LinkedIn  
  • Save this article
  • Print this page